This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ Blautia wexlerae {Blautia wexlerae}

AI Engines For more Details: Perplexity  Kagi Labs  You 

Check for interactions on Supp.AI   |   📚 PubMed Citations

Data Contradictions — Limits of Certainity

Impacted of Blautia wexlerae {Blautia wexlerae} On Probiotics

Rank Probiotic Impact
species Akkermansia muciniphila Increases

Bacteria Impacted by Blautia wexlerae {Blautia wexlerae}

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations 👪👶 Indirect Citations Taxonomy Rank Effect
0 1 Akkermansiaceae family Increases
1 0 Rikenellaceae family Increases
0 1 Acetobacteroides genus Increases
0 1 Anaerocella genus Increases
0 1 Butyricicoccus genus Increases
0 1 Gallalistipes genus Increases
0 1 Millionella genus Increases
0 1 Mucinivorans genus Increases
0 1 Rikenella genus Increases
0 1 Ruminofilibacter genus Increases
0 1 Tidjanibacter genus Increases
1 0 Akkermansia genus Increases
1 0 Alistipes genus Increases
0 1 environmental samples no rank Increases
0 1 environmental samples no rank Increases
0 1 environmental samples no rank Increases
0 1 Rikenellaceae incertae sedis no rank Increases
0 1 unclassified Akkermansia no rank Increases
0 1 unclassified Alistipes no rank Increases
0 1 unclassified Rikenellaceae no rank Increases
0 1 Bacteroidales order Increases
0 1 Akkermansia glycaniphila species Increases
0 1 Alistipes megaguti species Increases
0 1 Alistipes indistinctus species Increases
0 1 Alistipes dispar species Increases
0 1 Alistipes ihumii species Increases
0 1 Akkermansia massiliensis species Increases
0 1 Alistipes hominis species Increases
0 1 Alistipes inops species Increases
0 1 Alistipes massiliensis species Increases
0 1 Alistipes montrealensis species Increases
0 1 Alistipes provencensis species Increases
0 1 Alistipes putredinis species Increases
0 1 Alistipes timonensis species Increases
0 1 Candidatus Akkermansia intestinavium species Increases
0 1 Candidatus Alistipes avistercoris species Increases
0 1 Candidatus Alistipes cottocaccae species Increases
0 1 Candidatus Alistipes excrementavium species Increases
0 1 Candidatus Alistipes excrementigallinarum species Increases
0 1 Candidatus Alistipes excrementipullorum species Increases
0 1 Candidatus Alistipes faecigallinarum species Increases
0 1 Candidatus Alistipes intestinigallinarum species Increases
0 1 Candidatus Alistipes merdavium species Increases
0 1 Candidatus Alistipes merdipullorum species Increases
0 1 Candidatus Alistipes pullicola species Increases
0 1 Candidatus Alistipes pullistercoris species Increases
0 1 Candidatus Alistipes stercorigallinarum species Increases
0 1 Candidatus Alistipes stercoripullorum species Increases
0 1 Alistipes senegalensis species Increases
0 1 Alistipes shahii species Increases
0 1 Alistipes communis species Increases
0 1 Alistipes finegoldii species Increases
0 1 Alistipes onderdonkii species Increases
0 1 Akkermansia muciniphila species Increases
1 0 Butyricicoccus faecihominis species Increases

Impact of Blautia wexlerae {Blautia wexlerae} on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 0.3 0.3
ADHD 1.2 -1.2
Allergic Rhinitis (Hay Fever) 0.6 0.3 1
Allergies 1.8 0.9 1
Allergy to milk products 0.6 -0.6
Alzheimer's disease 0.9 2 -1.22
Amyotrophic lateral sclerosis (ALS) Motor Neuron 0.6 1.2 -1
Ankylosing spondylitis 0.6 1.2 -1
Anorexia Nervosa 0.6 -0.6
Asthma 1.5 1.5
Atherosclerosis 0.9 0.9
Atrial fibrillation 0.9 0.6 0.5
Autism 2.6 2.4 0.08
Bipolar Disorder 0.9 -0.9
Brain Trauma 0.3 0.3
Carcinoma 0.6 0.6 0
Celiac Disease 1.2 1.2
Cerebral Palsy 0.6 -0.6
Chronic Fatigue Syndrome 0.9 -0.9
Chronic Kidney Disease 0.9 0.9
Chronic Urticaria (Hives) 0.6 0.6
Cognitive Function 1.5 0.6 1.5
Colorectal Cancer 0.3 3.3 -10
COVID-19 3 2.1 0.43
Crohn's Disease 1.9 1.5 0.27
deep vein thrombosis 0.3 0.6 -1
Depression 3.8 2.7 0.41
Eczema 0.3 -0.3
Endometriosis 0.3 0.3
Epilepsy 1.2 2.2 -0.83
erectile dysfunction 0.6 0.6
Fibromyalgia 1.1 -1.1
Functional constipation / chronic idiopathic constipation 0.4 1.2 -2
gallstone disease (gsd) 1.2 1.2
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.6 0.3 1
Generalized anxiety disorder 0.9 0.6 0.5
giant cell arteritis 0.3 -0.3
Gout 1.5 0.9 0.67
Graves' disease 1.2 0.3 3
Gulf War Syndrome 1.2 1.2
Hashimoto's thyroiditis 0.6 1.2 -1
Heart Failure 0.6 0.6
hemorrhagic stroke 0.6 0.6 0
hypercholesterolemia (High Cholesterol) 0.6 0.6
hyperglycemia 1.2 0.6 1
Hyperlipidemia (High Blood Fats) 0.9 0.6 0.5
hypertension (High Blood Pressure 1.8 2.1 -0.17
Hypothyroidism 0.3 0.6 -1
Hypoxia 0.9 -0.9
IgA nephropathy (IgAN) 0.9 0.9
Inflammatory Bowel Disease 2.1 1.2 0.75
Insomnia 1.2 0.3 3
Intracranial aneurysms 0.6 -0.6
Irritable Bowel Syndrome 2.4 2.1 0.14
ischemic stroke 1.2 -1.2
Juvenile idiopathic arthritis 0.6 -0.6
Liver Cirrhosis 2.7 1.5 0.8
Long COVID 2.4 0.6 3
Low bone mineral density 0.6 0.6
Lung Cancer 1 1
Lymphoma 0.6 0.6
Mast Cell Issues / mastitis 0.9 0.9
ME/CFS with IBS 0.6 -0.6
Menopause 0.6 0.6
Metabolic Syndrome 2.1 2.4 -0.14
Mood Disorders 3 3.6 -0.2
multiple chemical sensitivity [MCS] 0.6 -0.6
Multiple Sclerosis 0.3 2.2 -6.33
Multiple system atrophy (MSA) 1.6 -1.6
neuropathic pain 0.6 0.6
Neuropathy (all types) 0.6 -0.6
neuropsychiatric disorders (PANDAS, PANS) 0.6 -0.6
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 2.4 0.6 3
NonCeliac Gluten Sensitivity 0.6 -0.6
Obesity 3.6 3.6 0
obsessive-compulsive disorder 0.6 0.6 0
Osteoarthritis 0.6 0.5 0.2
Osteoporosis 2.1 2.1
Parkinson's Disease 0.3 4.3 -13.33
Peanut Allergy 1.2 1.2
Polycystic ovary syndrome 2.1 0.6 2.5
Premenstrual dysphoric disorder 0.3 0.3
Psoriasis 1.2 0.6 1
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 0.6 0.9 -0.5
Schizophrenia 1.5 0.9 0.67
sensorineural hearing loss 0.6 -0.6
Sjögren syndrome 0.6 0.6 0
Sleep Apnea 1.2 1.2
Stress / posttraumatic stress disorder 0.6 0.6 0
Systemic Lupus Erythematosus 0.6 0.6
Tourette syndrome 0.6 -0.6
Type 1 Diabetes 1.2 -1.2
Type 2 Diabetes 2.1 1.8 0.17
Ulcerative colitis 2 1.2 0.67
Unhealthy Ageing 1.6 1.6
Vitiligo 0.9 0.9

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]